Latest Breaking News On - Syngene q2 earnings - Page 1 : comparemela.com

Net profit before an exceptional item rose 20% YoY to 122 crore. The exceptional item pertains to transaction costs relating to the acquisition of the multi-modal facility of Stelis Biopharma

Stelis biopharmaJonathan huntStelis biopharma ltdSyngene internationalQuality controlSyngene q2 resultsSyngene q2 results updateSyngene q2 earningsSyngene q2 earnings updateSyngene q2 news